Dymon Asia Capital »

Ionis Pharmaceuticals shares owned by Dymon Asia Capital

Quarter-by-quarter ownership of Ionis Pharmaceuticals (IONS) shares owned by Dymon Asia Capital from 13F filings

Historical chart of Dymon Asia Capital investment in Ionis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ionis Pharmaceuticals held by Dymon Asia Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ionis Pharmaceuticals by Dymon Asia Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $423k 5.4k 79.11

More positions owned by Dymon Asia Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Silver Tr Ishares Call Option (SLV)
NVIDIA Corporation (NVDA)
Ishares Tr Mbs Etf (MBB)
Meta Platforms Cl A Call Option (META)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Home Depot (HD)
Qualcomm (QCOM)
Synopsys Call Option (SNPS)
Spdr Gold Tr Gold Shs Call Option (GLD)
Alphabet Cap Stk Cl A (GOOGL)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)

View all positions for Dymon Asia Capital

Top funds holding Ionis Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
T. Rowe Price Investment Management
Wellington Management Company
Bellevue Group
State Street Corporation
Geode Capital Management
Citadel Advisors
Tweedy, Browne Company
Two Sigma Advisers
Deerfield Management Company
Summit Partners Public Asset Management
Deep Track Capital

View all funds holding Ionis Pharmaceuticals